Cardiologs puts its AI model up against the Apple Watch—and wins

Cardiologs, a Paris-based healthcare technology company, has announced that its own AI model can detect atrial arrhythmias (AAs) better than the Apple Watch’s electrocardiogram (ECG) algorithm. The company presented its data, based on a small clinical trial, Saturday, Nov. 13, at American Heart Association (AHA) Scientific Sessions 2021.

The analysis put a deep neural network (DNN) designed by Cardiologs up against the Apple Watch. Overall, Cardiologs announced, its DNN improved sensitivity by 34% and resulted in fewer unclassified readings.

“Cardiac monitoring is almost a standard feature of modern wearables like the Apple Watch, but there are still opportunities to improve ECG analysis to get a more accurate diagnosis,” Yann Fleureau, Cardiologs CEO and co-founder, said in a prepared statement. “It’s exciting to see that our deep learning algorithm can provide a more precise reading, promising many benefits for both patients and healthcare professionals. This advance will no doubt clear the path for the next generation of wearable health technology.”

In related news, Royal Philips recently announced that it has entered into an agreement to acquire Cardiologs. No financial details have been announced at this time.

More information on AHA Scientific Sessions 2021 can be found here.

Around the web

Mechanical engineers have developed injectable hydrogels that can fuse with frequently moving tissues—like those of the heart, muscles and vocal cords—to repair damage and restore function.

Researchers have demonstrated the 3D bioprinting of artificial human skin so lifelike it can quickly fuse with damaged tissue from the surface (epidermis) through the midlevel (dermis) and into the underlying fatty layer (hypodermis).

COVID-19 has taken a sizable bite out of physicians’ finances, and the AMA is now using such data to convince officials not to further reduce pay. 

Trimed Popup
Trimed Popup